Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

SIRIUS XM Radio Q1 Profit Rises - Quick Facts

RELATED NEWS
Trade SIRI now with 

SIRIUS XM Radio Inc. (SIRI: Quote) reported that its first-quarter net income was $107.77 million or $0.02 per share, up from $78.12 million or $0.01 per share in the same quarter last year.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.02 per share for the quarter. Analysts' estimates typically exclude special items.

Total revenues for the quarter rose to $804.72 million from $723.84 million in the prior year quarter. Eleven analysts had consensus revenue estimate of $803.83 million for the quarter.

Self-pay net subscriber additions improved by 148% to 299,348 and the subscriber base rose to an all-time high of 22.3 million subscribers.

The company now expects to grow its net new subscribers by 1.5 million in 2012. The company reiterated its existing 2012 revenue, adjusted EBITDA and free cash flow guidance. The company expects revenue of approximately $3.3 billion, Adjusted EBITDA of approximately $875 million, and Free cash flow of approximately $700 million.

Thirteen analysts have consensus revenue estimate of $3.36 billion for fiscal 2012.

Click here to receive FREE breaking news email alerts for SIRIUS XM Radio Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Bundesbank President Jens Weidmann has criticized the European Central Bank's latest measures to boost the euro area economy, such as the planned purchases of covered bonds and asset-backed securities and covered bonds, as well as the interest rate reduction this month. The latest decisions suggest... European stocks are seen opening lower on Monday, tracking weak commodity prices and a subdued trend across the Asia-Pacific region as investors look ahead to Chinese manufacturing data due on Tuesday for important clues about China's growth outlook. China is experiencing stable growth and there... Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.